SCHEMBL16274264

SCHEMBL16274264

CCOC(=O)CCN(C(=O)c1ccc2c(c1)nc(CC(c1ccccc1)c1ccc(C#N)cc1)n2C)c1ccccn1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NQO2 P16083 2/20 0.62
F2 P00734 15/20 0.54
NR1I2 O75469 1/20 0.54
ADORA3 P0DMS8 1/20 0.54
SLC6A2 P23975 1/20 0.54
AGTR1 P30556 1/20 0.54
SLC6A3 Q01959 1/20 0.54
SCN5A Q14524 1/20 0.54
SLC22A2 O15244 1/20 0.51
F10 P00742 1/20 0.51
PLG P00747 1/20 0.51
PLAT P00750 1/20 0.51
PROC P04070 1/20 0.51
HPN P05981 1/20 0.51
PRSS1 P07477 1/20 0.51
PRSS2 P07478 1/20 0.51
PRSS3 P35030 1/20 0.51
SLC47A2 Q86VL8 1/20 0.51
SLC47A1 Q96FL8 1/20 0.51
MEN1 O00255 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6780628 0.88 NQO2 (0.64) NQO2F2NR1I2ADORA3SLC6A2
SCHEMBL6775139 0.86 NQO2 (0.62) NQO2F2NR1I2ADORA3SLC6A2
SCHEMBL505917 0.86 NQO2 (0.82) NQO2F2NR1I2ADORA3SLC6A2
Acetic Acid SCHEMBL17065501 0.86 NQO2 (0.79) NQO2F2NR1I2ADORA3SLC6A2
Oxalic Acid SCHEMBL13684738 0.86 NQO2 (0.79) NQO2F2NR1I2ADORA3SLC6A2
Hydrochloric Acid SCHEMBL14696865 0.86 NQO2 (0.81) NQO2F2NR1I2ADORA3SLC6A2
Fumaric Acid SCHEMBL15415353 0.84 NQO2 (0.76) NQO2F2NR1I2ADORA3SLC6A2
SCHEMBL16583202 0.84 NQO2 (0.78) NQO2F2NR1I2ADORA3SLC6A2
SCHEMBL15483169 0.84 NQO2 (0.75) NQO2F2NR1I2ADORA3SLC6A2
SCHEMBL6784163 0.83 NQO2 (0.70) NQO2F2NR1I2ADORA3SLC6A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2014192030-A2 AN IMPROVED PROCESS FOR PREPARATION OF DABIGATRAN ETEXILATE AND PHARMACEUTICALLY ACCEPTABLE ACID ADDITION SALTS THEREOF LAURUS LABS PRIVATE LIMITED (IN) 2014-12-04 WO disclosed